Exp Clin Endocrinol Diabetes 1983; 81(2): 109-114
DOI: 10.1055/s-0029-1210216
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

The Synthetic Approach to STS 557 - Structure Activity Relationships in 17α-CH2X-Substituted 19-Nortestosterone Derivatives

M. Hübner, K. Ponsold
  • Academy of Sciences of the GDR, Research Centre of Molecular Biology and Medicine, Central Institute of Microbiology and Experimental Therapy (Director: Prof. Dr. U. Taubeneck), Jena/GDR
Weitere Informationen

Publikationsverlauf

1982

Publikationsdatum:
17. Juli 2009 (online)

Summary

The synthesis of 17α-CH2X-substituted 19-nortestosterone derivatives (X = halogen, CN, N3, OH, NH2 etc.) is described. Starting with 1, 4-dihydroestradiol 3-methyl ether the 17α-CH2X-17β-hydroxy-moiety was introduced via a 17β-spiroepoxide which could be cleaved with various nucleophilic agents giving the desired derivatives. In the McPhail assay with immature rabbits some of these substances showed good progestagenic activity on oral administration. The influence of structural modifications on the activity is discussed. The best effect is observed if an additional double bond is introduced in position 9(10). While the 19-nortestosterone derivative with X=CN has only an activity of about 20% of that of norethisterone acetate, the introduction of a second double bond leads to a compound (STS 557) which has an oral potency more than ten times as high as levonorgestrel.